ALTG · Alta Equipment Group Inc.

The reporting person was granted such time-based restricted stock units ("RSUs") for the annual director grant on the date of the 2026 Annual Meeting of Stockholders on May 29, 2026. Each RSU represents the right to receive one share of Common Stock. The RSUs vest 1/12th each month and fully vest on the date of the Annual Meeting of Stockholders the following year.

The reporting person was granted such time-based restricted stock units ("RSUs") for the annual director grant on the date of the 2026 Annual Meeting of Stockholders on May 29, 2026. Each RSU represents the right to receive one share of Common Stock. Subject to the reporting person's election to defer the receipt of the RSUs to the reporting person's termination of service as a director, the RSUs vest 1/12th each month and fully vest on the date of the Annual Meeting of Stockholders the following year.

The reporting person was granted such time-based restricted stock units ("RSUs") for the annual director grant on the date of the 2026 Annual Meeting of Stockholders on May 29, 2026. Each RSU represents the right to receive one share of Common Stock. Subject to the reporting person's election to defer the receipt of the RSUs to the reporting person's termination of service as a director, the RSUs vest 1/12th each month and fully vest on the date of the Annual Meeting of Stockholders the following year.

The reporting person was granted such time-based restricted stock units ("RSUs") for the annual director grant on the date of the 2026 Annual Meeting of Stockholders on May 29, 2026. Each RSU represents the right to receive one share of Common Stock. Subject to the reporting person's election to defer the receipt of the RSUs to the reporting person's termination of service as a director, the RSUs vest 1/12th each month and fully vest on the date of the Annual Meeting of Stockholders the following year.

The reporting person was granted such time-based restricted stock units ("RSUs") for the annual director grant on the date of the 2026 Annual Meeting of Stockholders on May 29, 2026. Each RSU represents the right to receive one share of Common Stock. Subject to the reporting person's election to defer the receipt of the RSUs to the reporting person's termination of service as a director, the RSUs vest 1/12th each month and fully vest on the date of the Annual Meeting of Stockholders the following year.

The shares reported are directly held by Mill Road Capital III, L.P. (the "Fund"). Mill Road Capital III GP LLC (the "GP") is the sole general partner of the Fund and has sole authority to vote (or direct the vote of), and to dispose (or direct the disposal) of, these shares on behalf of the Fund. Mr. Lynch is a management committee director of the GP and has shared authority to vote (or direct the vote of), and to dispose (or direct the disposal) of, these shares on behalf of the GP. Each of the Reporting Persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any.

The shares reported are directly held by Mill Road Capital III, L.P. (the "Fund"). Mill Road Capital III GP LLC (the "GP") is the sole general partner of the Fund and has sole authority to vote (or direct the vote of), and to dispose (or direct the disposal) of, these shares on behalf of the Fund. Mr. Lynch is a management committee director of the GP and has shared authority to vote (or direct the vote of), and to dispose (or direct the disposal) of, these shares on behalf of the GP. Each of the Reporting Persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any.

These shares were purchased in one transaction at the disclosed price.

The shares reported are directly held by Mill Road Capital III, L.P. (the "Fund"). Mill Road Capital III GP LLC (the "GP") is the sole general partner of the Fund and has sole authority to vote (or direct the vote of), and to dispose (or direct the disposal) of, these shares on behalf of the Fund. Mr. Lynch is a management committee director of the GP and has shared authority to vote (or direct the vote of), and to dispose (or direct the disposal) of, these shares on behalf of the GP. Each of the Reporting Persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any.

These shares were purchased in one transaction at the disclosed price.

These shares were purchased in one transaction at the disclosed price.

These shares were purchased in one transaction at the disclosed price.

The reporting person was granted performance stock units ("PSUs") under the Alta Equipment Group Inc. 2020 Omnibus Incentive Plan. Each PSU represents the right to receive one share of Common Stock. The PSUs were earned on February 27, 2026 and will vest annually over 2 years starting on February 14, 2027, subject to reporting person's continued employment with the Company.

The reporting person was granted performance stock units ("PSUs") under the Alta Equipment Group Inc. 2020 Omnibus Incentive Plan. Each PSU represents the right to receive one share of Common Stock. The PSUs were earned on February 27, 2026 and will vest annually over 2 years starting on February 14, 2027, subject to reporting person's continued employment with the Company.

The reporting person was granted performance stock units ("PSUs") under the Alta Equipment Group Inc. 2020 Omnibus Incentive Plan. Each PSU represents the right to receive one share of Common Stock. The PSUs were earned on February 27, 2026 and will vest annually over 2 years starting on February 14, 2027, subject to reporting person's continued employment with the Company.

The price reported in Column 4 reflects a weighted average price. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, specific trade amounts and pricing within the ranges set forth below.

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.97 and $5.15, inclusive.

The reporting person was granted such time-based restricted stock units ("RSUs") for the annual director grant on the date of the 2025 Annual Meeting of Stockholders on May 30, 2025. Each RSU represents the right to receive one share of Common Stock. Subject to the reporting person's election to defer the receipt of the RSUs to the reporting person's termination of service as a director, the RSUs vest 1/12th each month and fully vest on the date of the Annual Meeting of Stockholders the following year.

The reporting person was granted such time-based restricted stock units ("RSUs") for the annual director grant on the date of the 2025 Annual Meeting of Stockholders on May 30, 2025. Each RSU represents the right to receive one share of Common Stock. The RSUs vest 1/12th each month and fully vest on the date of the Annual Meeting of Stockholders the following year.

The price reported in Column 4 reflects a weighted average price. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, specific trade amounts and pricing within the ranges set forth below.

The price reported in Column 4 is a weighted average price. These shares were purchased in one transaction at a price of $4.805.

The reporting person was granted such time-based restricted stock units ("RSUs") for the annual director grant on the date of the 2025 Annual Meeting of Stockholders on May 30, 2025. Each RSU represents the right to receive one share of Common Stock. Subject to the reporting person's election to defer the receipt of the RSUs to the reporting person's termination of service as a director, the RSUs vest 1/12th each month and fully vest on the date of the Annual Meeting of Stockholders the following year.

The reporting person was granted such time-based restricted stock units ("RSUs") for the annual director grant on the date of the 2025 Annual Meeting of Stockholders on May 30, 2025. Each RSU represents the right to receive one share of Common Stock. The RSUs vested immediately due to the reporting person's service as a director from his appointment date, September 1, 2024 through the 2025 Annual Meeting of Stockholders and will be deferred subject to the reporting person's election to defer the receipt of the RSUs to the reporting person's termination of service as a director.

The reporting person was granted such time-based restricted stock units ("RSUs") for the annual director grant on the date of the 2025 Annual Meeting of Stockholders on May 30, 2025. Each RSU represents the right to receive one share of Common Stock. Subject to the reporting person's election to defer the receipt of the RSUs to the reporting person's termination of service as a director, the RSUs vest 1/12th each month and fully vest on the date of the Annual Meeting of Stockholders the following year.

The reporting person was granted such time-based restricted stock units ("RSUs") for the annual director grant on the date of the 2025 Annual Meeting of Stockholders on May 30, 2025. Each RSU represents the right to receive one share of Common Stock. Subject to the reporting person's election to defer the receipt of the RSUs to the reporting person's termination of service as a director, the RSUs vest 1/12th each month and fully vest on the date of the Annual Meeting of Stockholders the following year.

The price reported in Column 4 reflects a weighted average price. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, specific trade amounts and pricing within the ranges set forth below.

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.79 and $4.8184, inclusive.

The reporting person was granted restricted stock units ("RSUs") under the Alta Equipment Group Inc. 2020 Omnibus Incentive Plan. Each RSU represents the right to receive one share of Common Stock. The RSUs will vest annually over 3 years starting on February 14, 2026, subject to reporting person's continued employment with the Company.

The reporting person was granted restricted stock units ("RSUs") under the Alta Equipment Group Inc. 2020 Omnibus Incentive Plan. Each RSU represents the right to receive one share of Common Stock. The RSUs will vest annually over 3 years starting on February 14, 2026, subject to reporting person's continued employment with the Company.

The reporting person was granted restricted stock units ("RSUs") under the Alta Equipment Group Inc. 2020 Omnibus Incentive Plan. Each RSU represents the right to receive one share of Common Stock. The RSUs will vest annually over 3 years starting on February 14, 2026, subject to reporting person's continued employment with the Company.

The reporting person was granted restricted stock units ("RSUs") under the Alta Equipment Group Inc. 2020 Omnibus Incentive Plan. Each RSU represents the right to receive one share of Common Stock. The RSUs will vest annually over 3 years starting on February 14, 2026, subject to reporting person's continued employment with the Company.

The shares sold relate to a "sell to cover" transaction to pay tax withholding obligations on the vesting of previously issued performance and restricted stock units in accordance with the Company's 2020 Omnibus Incentive Plan.

On January 24, 2025, in connection with his estate planning, Mr. Shribman transferred 91,393 shares of the issuer's common stock for no consideration to Clamantis Holdings, LLC, an entity 100% owned and controlled by Mr. Shribman. Mr. Shribman has voting power over the shares as owner of Clamantis Holdings, LLC.

On January 24, 2025, in connection with his estate planning, Mr. Shribman transferred 91,393 shares of the issuer's common stock for no consideration to Clamantis Holdings, LLC, an entity 100% owned and controlled by Mr. Shribman. Mr. Shribman has voting power over the shares as owner of Clamantis Holdings, LLC.

Each put option became exercisable on the date purchased, which dates range from 7/24/2024 to 7/29/2024.

The shares reported are directly held by Mill Road Capital III, L.P. (the "Fund"). Mill Road Capital III GP LLC (the "GP") is the sole general partner of the Fund and has sole authority to vote (or direct the vote of), and to dispose (or direct the disposal) of, these shares on behalf of the Fund. Mr. Lynch is a management committee director of the GP and has shared authority to vote (or direct the vote of), and to dispose (or direct the disposal) of, these shares on behalf of the GP. Each of the Reporting Persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any.

The shares reported are directly held by Mill Road Capital III, L.P. (the "Fund"). Mill Road Capital III GP LLC (the "GP") is the sole general partner of the Fund and has sole authority to vote (or direct the vote of), and to dispose (or direct the disposal) of, these shares on behalf of the Fund. Mr. Lynch is a management committee director of the GP and has shared authority to vote (or direct the vote of), and to dispose (or direct the disposal) of, these shares on behalf of the GP. Each of the Reporting Persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any.

The shares reported are directly held by Mill Road Capital III, L.P. (the "Fund"). Mill Road Capital III GP LLC (the "GP") is the sole general partner of the Fund and has sole authority to vote (or direct the vote of), and to dispose (or direct the disposal) of, these shares on behalf of the Fund. Mr. Lynch is a management committee director of the GP and has shared authority to vote (or direct the vote of), and to dispose (or direct the disposal) of, these shares on behalf of the GP. Each of the Reporting Persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any.

Each put option became exercisable on the date purchased, which dates range from 7/24/2024 to 7/29/2024.

The shares reported are directly held by Mill Road Capital III, L.P. (the "Fund"). Mill Road Capital III GP LLC (the "GP") is the sole general partner of the Fund and has sole authority to vote (or direct the vote of), and to dispose (or direct the disposal) of, these shares on behalf of the Fund. Mr. Lynch is a management committee director of the GP and has shared authority to vote (or direct the vote of), and to dispose (or direct the disposal) of, these shares on behalf of the GP. Each of the Reporting Persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any.

Each put option became exercisable on the date purchased, which dates range from 7/24/2024 to 7/29/2024.

The shares reported are directly held by Mill Road Capital III, L.P. (the "Fund"). Mill Road Capital III GP LLC (the "GP") is the sole general partner of the Fund and has sole authority to vote (or direct the vote of), and to dispose (or direct the disposal) of, these shares on behalf of the Fund. Mr. Lynch is a management committee director of the GP and has shared authority to vote (or direct the vote of), and to dispose (or direct the disposal) of, these shares on behalf of the GP. Each of the Reporting Persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any.

The shares reported are directly held by Mill Road Capital III, L.P. (the "Fund"). Mill Road Capital III GP LLC (the "GP") is the sole general partner of the Fund and has sole authority to vote (or direct the vote of), and to dispose (or direct the disposal) of, these shares on behalf of the Fund. Mr. Lynch is a management committee director of the GP and has shared authority to vote (or direct the vote of), and to dispose (or direct the disposal) of, these shares on behalf of the GP. Each of the Reporting Persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any.

Each put option became exercisable on the date purchased, which dates range from 7/24/2024 to 7/29/2024.

The shares reported are directly held by Mill Road Capital III, L.P. (the "Fund"). Mill Road Capital III GP LLC (the "GP") is the sole general partner of the Fund and has sole authority to vote (or direct the vote of), and to dispose (or direct the disposal) of, these shares on behalf of the Fund. Mr. Lynch is a management committee director of the GP and has shared authority to vote (or direct the vote of), and to dispose (or direct the disposal) of, these shares on behalf of the GP. Each of the Reporting Persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any.

The shares reported are directly held by Mill Road Capital III, L.P. (the "Fund"). Mill Road Capital III GP LLC (the "GP") is the sole general partner of the Fund and has sole authority to vote (or direct the vote of), and to dispose (or direct the disposal) of, these shares on behalf of the Fund. Mr. Lynch is a management committee director of the GP and has shared authority to vote (or direct the vote of), and to dispose (or direct the disposal) of, these shares on behalf of the GP. Each of the Reporting Persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any.

The shares reported are directly held by Mill Road Capital III, L.P. (the "Fund"). Mill Road Capital III GP LLC (the "GP") is the sole general partner of the Fund and has sole authority to vote (or direct the vote of), and to dispose (or direct the disposal) of, these shares on behalf of the Fund. Mr. Lynch is a management committee director of the GP and has shared authority to vote (or direct the vote of), and to dispose (or direct the disposal) of, these shares on behalf of the GP. Each of the Reporting Persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any.

Each put option became exercisable on the date purchased, which dates range from 7/24/2024 to 7/29/2024.

The shares reported are directly held by Mill Road Capital III, L.P. (the "Fund"). Mill Road Capital III GP LLC (the "GP") is the sole general partner of the Fund and has sole authority to vote (or direct the vote of), and to dispose (or direct the disposal) of, these shares on behalf of the Fund. Mr. Lynch is a management committee director of the GP and has shared authority to vote (or direct the vote of), and to dispose (or direct the disposal) of, these shares on behalf of the GP. Each of the Reporting Persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any.

This Form 4 is filed jointly by Voss Value Master Fund, L.P. ("Voss Value Master Fund"), Voss Value-Oriented Special Situations Fund, L.P. ("Voss Value-Oriented Special Situations Fund"), Voss Advisors GP, LLC ("Voss GP"), Voss Capital, L.P. ("Voss Capital") and Travis W. Cocke (collectively, the "Reporting Persons"). Each Reporting Person disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

Securities owned directly by Voss Value Master Fund. Voss GP, as the general partner of Voss Value Master Fund, may be deemed to beneficially own the securities owned directly by Voss Value Master Fund. Voss Capital, as the investment manager of Voss Value Master Fund, may be deemed to beneficially own the securities owned directly by Voss Value Master Fund. Mr. Cocke, as the managing member of Voss Capital and Voss GP, may be deemed to beneficially own the securities owned directly by Voss Value Master Fund.

The shares reported are directly held by Mill Road Capital III, L.P. (the "Fund"). Mill Road Capital III GP LLC (the "GP") is the sole general partner of the Fund and has sole authority to vote (or direct the vote of), and to dispose (or direct the disposal) of, these shares on behalf of the Fund. Mr. Lynch is a management committee director of the GP and has shared authority to vote (or direct the vote of), and to dispose (or direct the disposal) of, these shares on behalf of the GP. Each of the Reporting Persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any.

Each put option became exercisable on the date purchased, which dates range from 7/24/2024 to 7/30/2024.

The shares reported are directly held by Mill Road Capital III, L.P. (the "Fund"). Mill Road Capital III GP LLC (the "GP") is the sole general partner of the Fund and has sole authority to vote (or direct the vote of), and to dispose (or direct the disposal) of, these shares on behalf of the Fund. Mr. Lynch is a management committee director of the GP and has shared authority to vote (or direct the vote of), and to dispose (or direct the disposal) of, these shares on behalf of the GP. Each of the Reporting Persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any.

The shares reported are directly held by Mill Road Capital III, L.P. (the "Fund"). Mill Road Capital III GP LLC (the "GP") is the sole general partner of the Fund and has sole authority to vote (or direct the vote of), and to dispose (or direct the disposal) of, these shares on behalf of the Fund. Mr. Lynch is a management committee director of the GP and has shared authority to vote (or direct the vote of), and to dispose (or direct the disposal) of, these shares on behalf of the GP. Each of the Reporting Persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any.

The shares reported are directly held by Mill Road Capital III, L.P. (the "Fund"). Mill Road Capital III GP LLC (the "GP") is the sole general partner of the Fund and has sole authority to vote (or direct the vote of), and to dispose (or direct the disposal) of, these shares on behalf of the Fund. Mr. Lynch is a management committee director of the GP and has shared authority to vote (or direct the vote of), and to dispose (or direct the disposal) of, these shares on behalf of the GP. Each of the Reporting Persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any.

The shares reported are directly held by Mill Road Capital III, L.P. (the "Fund"). Mill Road Capital III GP LLC (the "GP") is the sole general partner of the Fund and has sole authority to vote (or direct the vote of), and to dispose (or direct the disposal) of, these shares on behalf of the Fund. Mr. Lynch is a management committee director of the GP and has shared authority to vote (or direct the vote of), and to dispose (or direct the disposal) of, these shares on behalf of the GP. Each of the Reporting Persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any.

Each put option became exercisable on the date purchased, which dates range from 7/19/2024 to 7/22/2024.

The shares reported are directly held by Mill Road Capital III, L.P. (the "Fund"). Mill Road Capital III GP LLC (the "GP") is the sole general partner of the Fund and has sole authority to vote (or direct the vote of), and to dispose (or direct the disposal) of, these shares on behalf of the Fund. Mr. Lynch is a management committee director of the GP and has shared authority to vote (or direct the vote of), and to dispose (or direct the disposal) of, these shares on behalf of the GP. Each of the Reporting Persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any.

The shares reported are directly held by Mill Road Capital III, L.P. (the "Fund"). Mill Road Capital III GP LLC (the "GP") is the sole general partner of the Fund and has sole authority to vote (or direct the vote of), and to dispose (or direct the disposal) of, these shares on behalf of the Fund. Mr. Lynch is a management committee director of the GP and has shared authority to vote (or direct the vote of), and to dispose (or direct the disposal) of, these shares on behalf of the GP. Each of the Reporting Persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any.